ERK1 (phospho Thr202/Tyr204) + ERK2 (phospho Thr185/Tyr187) antibody [MAPK-YT]
GTX01452
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat, Yeast
TargetMapk3
Overview
- SupplierGeneTex
- Product NameERK1 (phospho Thr202/Tyr204) + ERK2 (phospho Thr185/Tyr187) antibody [MAPK-YT]
- Delivery Days Customer9
- Antibody SpecificitySuperfamily members of Mapk3 are not reactive to this antibody.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDMAPK-YT
- ConjugateUnconjugated
- Gene ID50689
- Target nameMapk3
- Target descriptionmitogen activated protein kinase 3
- Target synonymsERK1; Erk-1; ERT2; Esrk1; extracellular signal-regulated kinase 1; insulin-stimulated MAP2 kinase; MAP kinase 1; MAP kinase 3; MAPK 1; MAPK 3; MAPK1; microtubule-associated protein 2 kinase; mitogen-activated 3; mitogen-activated protein kinase 1; mitogen-activated protein kinase 3; MNK1; p44; p44erk1; p44mapk; Prkm3
- HostMouse
- IsotypeIgG1
- Modification TypePhosphorylated
- ReactivityHuman, Mouse, Rat, Yeast
- Storage Instruction2°C to 8°C,-20°C or -80°C
- UNSPSC12352203
References
- Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma. Zhu Z et al., 2015 Sep 4, J Exp Clin Cancer ResRead more
- Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study. Zhang Z et al., 2009 Aug 24, BMC MedRead more